Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury

Clinical trial NCT01676441 · TERMINATED

Trial details

NCT number: NCT01676441
Sponsor: Pharmicell Co., Ltd.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Spinal Cord Injury

Start date: 2008-08-01
Primary completion: 2021-03-04
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.